Paul E. Zarek

Array ( [id] => 9175129 [patent_doc_number] => 20130317115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'Composition and Method for Treating Neurological Disease' [patent_app_type] => utility [patent_app_number] => 13/958153 [patent_app_country] => US [patent_app_date] => 2013-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11294 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13958153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9148961 [patent_doc_number] => 20130303484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'Prodrugs of Modulators of ABC Transporters' [patent_app_type] => utility [patent_app_number] => 13/938768 [patent_app_country] => US [patent_app_date] => 2013-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19245 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13938768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135699 [patent_doc_number] => 20130296414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => '1-Phenyl-2-Dimethylaminomethyl Cyclohexane Compounds And Therapies For Depressive Symptoms, Pain and Incontinence' [patent_app_type] => utility [patent_app_number] => 13/935144 [patent_app_country] => US [patent_app_date] => 2013-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5375 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9759750 [patent_doc_number] => RE045173 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2014-09-30 [patent_title] => 'Inhibitors of CYP 17' [patent_app_type] => reissue [patent_app_number] => 13/929901 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72384 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9469043 [patent_doc_number] => 08722675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'Method of treatment or prophylaxis' [patent_app_type] => utility [patent_app_number] => 13/923085 [patent_app_country] => US [patent_app_date] => 2013-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 36573 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9205029 [patent_doc_number] => 20140004206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT AND SKIN TIGHTENING' [patent_app_type] => utility [patent_app_number] => 13/917450 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20651 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338313 [patent_doc_number] => 20140065095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'NOVEL INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/910702 [patent_app_country] => US [patent_app_date] => 2013-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 107687 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13910702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10049693 [patent_doc_number] => 09089547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Use of equol for treating androgen mediated diseases' [patent_app_type] => utility [patent_app_number] => 13/903748 [patent_app_country] => US [patent_app_date] => 2013-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 62 [patent_no_of_words] => 17602 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13903748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9396107 [patent_doc_number] => 20140093513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'METHODS OF LOWERING PROPROTEIN CONVERSATE SUBTILISIN/KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 13/902360 [patent_app_country] => US [patent_app_date] => 2013-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28968 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13902360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10280055 [patent_doc_number] => 20150165052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'Hybrid Opioid Compounds and Compositions' [patent_app_type] => utility [patent_app_number] => 13/891793 [patent_app_country] => US [patent_app_date] => 2013-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20946 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13891793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9042407 [patent_doc_number] => 20130245045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'SELECTIVE PHOSPHODIESTERASE 9A INHIBITORS AS MEDICAMENTS FOR IMPROVING COGNITIVE PROCESSES' [patent_app_type] => utility [patent_app_number] => 13/886850 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5197 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034830 [patent_doc_number] => 20130237468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'SKIN CLEANSING AGENT, PARTICULARLY FOR REMOVING PRINTING INKS AND/OR SOILING CAUSED BY INK' [patent_app_type] => utility [patent_app_number] => 13/872599 [patent_app_country] => US [patent_app_date] => 2013-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3260 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870379 [patent_doc_number] => 08895577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Compounds and compositions as TLR activity modulators' [patent_app_type] => utility [patent_app_number] => 13/867752 [patent_app_country] => US [patent_app_date] => 2013-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 122860 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13867752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9016345 [patent_doc_number] => 20130231309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'TREATMENT OF INFLAMMATION AND ORGAN DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 13/862284 [patent_app_country] => US [patent_app_date] => 2013-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13192 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13862284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9839651 [patent_doc_number] => 20150031734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING MIRABEGRON' [patent_app_type] => utility [patent_app_number] => 14/388099 [patent_app_country] => US [patent_app_date] => 2013-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16034 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122196 [patent_doc_number] => 20130289118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'DERIVATIVES OF AMINOALKANOLS, METHOD OF OBTAINING OF AMINOALKANOLS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/853542 [patent_app_country] => US [patent_app_date] => 2013-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22325 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13853542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122201 [patent_doc_number] => 20130289123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'Compositions and Methods for Inhibiting an Isoform of Human Manganese Superoxide Dismutase' [patent_app_type] => utility [patent_app_number] => 13/853022 [patent_app_country] => US [patent_app_date] => 2013-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21323 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13853022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10533789 [patent_doc_number] => 09259404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => '4-oxo-2-pentenoic acid and brain health' [patent_app_type] => utility [patent_app_number] => 14/389082 [patent_app_country] => US [patent_app_date] => 2013-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6387 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9206026 [patent_doc_number] => 20140005203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Treatment of Vasomotor Symptoms' [patent_app_type] => utility [patent_app_number] => 13/847683 [patent_app_country] => US [patent_app_date] => 2013-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2708 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135522 [patent_doc_number] => 20130296237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'Use Of Chloroquine To Treat Metabolic Syndrome' [patent_app_type] => utility [patent_app_number] => 13/826270 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22521 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826270 [rel_patent_id] =>[rel_patent_doc_number] =>)